Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors

Details for Australian Patent Application No. 2010202035 (hide)

Owner Glaxo Group Limited

Inventors Redgrave, Alison Judith; Cooper, Anthony William James; Cook, Caroline Mary; Mitchell, Charlotte Jane; Edlin, Christopher David; Allen, David George; Coe, Diane Mary; Hamblin, Julie Nicole; Johnson, Martin Redpath; Dowle, Michael Dennis; Lindvall, Mika Kristian; Jones, Paul Spencer

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2010202035

Parent 2003293999

Filing date 19 May 2010

Wipo publication date 10 June 2010

Acceptance publication date 30 August 2012

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437

A61P 25/00 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

3 June 2010 Complete Application Filed

10 June 2010 Application Open to Public Inspection

  Published as AU-B-2010202035

30 August 2012 Application Accepted

  Published as AU-B-2010202035

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202036-Multi-dynamic-range sensor

2010202034-Partial object distribution in content delivery network